Peter Mačinga

662 total citations
17 papers, 374 citations indexed

About

Peter Mačinga is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Mačinga has authored 17 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Mačinga's work include IgG4-Related and Inflammatory Diseases (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Gastrointestinal disorders and treatments (3 papers). Peter Mačinga is often cited by papers focused on IgG4-Related and Inflammatory Diseases (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Gastrointestinal disorders and treatments (3 papers). Peter Mačinga collaborates with scholars based in Czechia, Germany and United States. Peter Mačinga's co-authors include Julius Špičák, Lukáš Bajer, Jan Březina, Pavel Drastich, Pavel Wohl, Martin Kostovčík, Jiří Dvořák, Miloslav Kverka, Zuzana Stehlíková and Tomáš Hucl and has published in prestigious journals such as Clinical Cancer Research, World Journal of Gastroenterology and Obesity Surgery.

In The Last Decade

Peter Mačinga

14 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Mačinga Czechia	8	153	136	129	96	66	17	374
Lukáš Bajer Czechia	10	260 1.7×	130 1.0×	181 1.4×	102 1.1×	137 2.1×	25	504
Toshinao Itani Japan	8	142 0.9×	105 0.8×	150 1.2×	105 1.1×	80 1.2×	22	401
Urszula Daniluk Poland	11	158 1.0×	132 1.0×	94 0.7×	33 0.3×	116 1.8×	44	429
Pavel Wohl Czechia	6	178 1.2×	93 0.7×	164 1.3×	98 1.0×	114 1.7×	19	414
Franziska Durchschein Austria	7	129 0.8×	86 0.6×	166 1.3×	130 1.4×	72 1.1×	17	376
Andreas Koutsoumpas United Kingdom	11	194 1.3×	148 1.1×	199 1.5×	88 0.9×	215 3.3×	29	563
Lorenzo Zileri Dal Verme Italy	11	286 1.9×	144 1.1×	147 1.1×	82 0.9×	190 2.9×	28	595
Jan Březina Czechia	6	214 1.4×	118 0.9×	141 1.1×	97 1.0×	100 1.5×	12	422
Elham Ahmed Hassan Egypt	12	156 1.0×	60 0.4×	177 1.4×	139 1.4×	35 0.5×	40	457

Countries citing papers authored by Peter Mačinga

Since Specialization

Citations

This map shows the geographic impact of Peter Mačinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mačinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mačinga more than expected).

Fields of papers citing papers by Peter Mačinga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mačinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mačinga. The network helps show where Peter Mačinga may publish in the future.

Co-authorship network of co-authors of Peter Mačinga

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mačinga. A scholar is included among the top collaborators of Peter Mačinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Mačinga. Peter Mačinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Janoštiak, Radoslav, et al.. (2024). Abstract B037: Disks large-associated protein 5 (DLGAP5) is a putative prognostic biomarker for intraductal papillary mucinous neoplasm (IPMN) of pancreas. Clinical Cancer Research. 30(21_Supplement). B037–B037.

Franeková, Janka, et al.. (2023). Significant elevations of serum amylase caused by macroamylase: Case reports and detection possibilities. Journal of Clinical Laboratory Analysis. 37(5). e24859–e24859. 2 indexed citations

Král, Jan, Věra Lánská, Peter Mačinga, et al.. (2023). Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes. Obesity Surgery. 34(5). 1407–1414. 2 indexed citations

Mačinga, Peter, et al.. (2022). Acute Pancreatitis in Patients After Liver Transplantation. Annals of Transplantation. 27. e938114–e938114. 4 indexed citations

Mačinga, Peter, Jan Mareš, Ondřej Urban, et al.. (2022). Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma. Biomedicines. 10(6). 1331–1331. 11 indexed citations

Mačinga, Peter, Lukáš Bajer, Marco Del Chiaro, et al.. (2021). Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Pancreatology. 21(5). 928–937. 16 indexed citations

Mačinga, Peter, Jana Jarošová, Julius Špičák, & Tomáš Hucl. (2021). Immunoglobulin G4-related disease in gastroenterology. Vnitřní lékařství. 67(2). 76–83. 1 indexed citations

Mačinga, Peter, et al.. (2021). Endoscopic radiofrequency ablation for malignant biliary obstruction. World Journal of Gastrointestinal Oncology. 13(10). 1383–1396. 10 indexed citations

Lanzillotta, Marco, Kasper A. Overbeek, Jakob Lykke Poulsen, et al.. (2020). PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis. Frontiers in Medicine. 7. 408–408. 9 indexed citations

10.

Opattová, Alena, Soňa Vodenková, Klara Kostovcikova, et al.. (2019). Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 845. 403065–403065. 26 indexed citations

11.

Mačinga, Peter, Lukáš Bajer, Soňa Fraňková, et al.. (2019). Pancreatic cancer in liver transplant recipients. Pancreatology. 19. S58–S58.

12.

Heczková, Marie, Eva Macháčková, Peter Mačinga, et al.. (2019). Functional evaluation of variants of unknown significance in theBRCA2gene identified in genetic testing. Cancer Biology & Therapy. 20(5). 633–641. 1 indexed citations

13.

Bajer, Lukáš, Antonij Slavčev, Peter Mačinga, et al.. (2018). Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease. World Journal of Gastroenterology. 24(43). 4939–4949. 10 indexed citations

14.

Mačinga, Peter, Lukáš Bajer, Jana Malušková, et al.. (2017). Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass. World Journal of Gastroenterology. 23(12). 2185–2185. 19 indexed citations

15.

Bajer, Lukáš, Miloslav Kverka, Martin Kostovčík, et al.. (2017). Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World Journal of Gastroenterology. 23(25). 4548–4548. 262 indexed citations

16.

Mačinga, Peter, et al.. (2016). Pancreatic cystic lesions in liver transplant recipients. 70(4). 295–299.

17.

Mačinga, Peter, et al.. (2016). Pancreatic cystic lesions in liver transplant recipients: Prevalence and outcome. Pancreatology. 16(3). S105–S105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact